UAB Research Foundation;Lipimetix Development, LLC
发明人:
GOLDBERG, Dennis,ANANTHARAMAIAH, Gattadahalli M.
申请号：
DK14769489
公开号：
DK2996706T3
申请日:
2014.03.14
申请国别(地区):
DK
年份:
2019
代理人:
摘要：
The disclosure provides dosing regimens and methods for treating atherosclerosis with an effective amount of Apo E mimetic to provide sustained therapeutic effects even after withdrawal of the treatment. The dosing regimens and methods involve a treatment cycle followed by a rest phase wherein a subject is administered an effective amount of an Apo E mimetic during the treatment cycle and no Apo E mimetic during the rest phase. The treatment cycle and the rest phase can vary.
